Unlock instant, AI-driven research and patent intelligence for your innovation.

Pharmaceutical composition for treating colorectal cancer and application thereof

A composition and drug technology, applied in the field of chemical medicine, can solve problems such as unsatisfactory curative effect, and achieve the effect of good therapeutic effect

Pending Publication Date: 2022-07-22
JENKEM TECH
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, studies have found that the curative effect of PEG-modified IL-2 on colorectal cancer and other tumors is still unsatisfactory, and it is necessary to further develop more effective drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating colorectal cancer and application thereof
  • Pharmaceutical composition for treating colorectal cancer and application thereof
  • Pharmaceutical composition for treating colorectal cancer and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0093] Example 1: Preparation of PEGylation reaction mixture

[0094] Take IL-2 protein (provided by Beijing Jiankai Technology Co., Ltd.), exchange it into 5mM PB pH 7.0 buffer, and add PEG modifier (provided by Beijing Jiankai Technology Co., Ltd.) according to a certain reaction molar ratio, Mix well, shake the reaction at room temperature for 2 hours, and check the preparation of the reaction mixture by HPLC after the reaction. The result is as figure 1 and shown in Table 1.

[0095] The structure of the PEG modifier used is shown below, with a molecular weight of 20,000 Dalton:

[0096]

[0097] Table 1 Component analysis of the reaction mixture (UV-0217-0002)

[0098]

[0099] The results showed that 2PEG-IL2 accounted for about 37%.

Embodiment 2

[0100] Example 2: Separation of 2PEG-IL2 by CM chromatography

[0101] The reaction mixture obtained in Example 1 was diluted with water while the pH was adjusted to 3.0 and the conductivity was 1.5 mS / cm, and the samples were loaded into the equilibrated CM column through the AKTA chromatography system, with 10 mM pH 3.0 sodium acetate buffer as A Phase, taking 10mM sodium acetate buffer containing 1M NaCl pH 3.0 as phase B, adopting phase B phase gradient elution, collect the elution fraction when the concentration of phase B is 8%, and analyze the purity by HPLC, that is, 2 PEG-IL2 samples.

[0102] The separated samples of 2PEG-IL2 were exchanged into 5mM PB pH 7.0 buffer using a G25 desalting column for use.

[0103] CM chromatographic separation pattern such as figure 2 shown. Using CM ion-exchange column chromatography resin, the samples coupled with different PEGs were separated by elution with increasing salt concentration. The peaks from left to right were 3PEG-I...

Embodiment 3

[0104] Example 3: alpha affinity chromatography

[0105] Specific steps are as follows:

[0106] (1) Equilibrate the filler with 5mM PB pH7.0 buffer;

[0107] (2) loading the sample obtained in Example 2 into the affinity filler;

[0108] (3) Elution is carried out with the configured eluent, and the elution samples are collected;

[0109] (4) Using the G25 desalting column to exchange the collected elution samples into 5mM PB pH7.0 buffer;

[0110] (5) Concentrate the sample obtained in step (4), filter and sterilize it through a 0.22 μm filter, and check the purity by HPLC.

[0111] 2PEG-IL2 sample purity analysis map such as image 3 As shown, the final desired 2PEG-IL2 was obtained.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention discloses a medicine composition for treating colorectal cancer and application thereof. The active ingredients of the pharmaceutical composition comprise polyethylene glycol modified IL-2 and capecitabine, the pharmaceutical composition shows a very good treatment effect in a colon cancer animal model, the effect is remarkably superior to that of a single drug, and the pharmaceutical composition has a relatively good application prospect.

Description

technical field [0001] The invention relates to the technical field of chemical medicine, in particular to a pharmaceutical composition for treating colorectal cancer and its application. Background technique [0002] Colorectal cancer (CRC) is one of the most common malignant tumors of the digestive tract, with 1.1 million new cases and about 500,000 deaths worldwide every year. According to the latest global cancer burden data released by the World Health Organization's International Agency for Research on Cancer (IARC) in 2020, colorectal cancer has become the third most common cancer worldwide after lung cancer. In recent years, with the intensification of population aging and changes in dietary structure in my country, the incidence and mortality of colorectal cancer in China have maintained an upward trend, and the age of onset has also tended to be younger. Therefore, reducing the morbidity and mortality of colorectal cancer in my country is a public health problem t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/20A61K47/60A61K45/06A61P35/00A61K31/7068
CPCA61K38/2013A61K31/7068A61K47/60A61K45/06A61P35/00A61K2300/00
Inventor 刘彪王庆彬郑喜春李秋芬王杰郭军赵宣
Owner JENKEM TECH